Tehran University of Medical Sciences

Science Communicator Platform

Share By
Serological Tests for Covid-19: Potential Opportunities Publisher Pubmed



Tantuoyir MM1, 2, 3 ; Rezaei N1, 4, 5
Authors

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific immunoglobulin M (IgM) and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge. © 2020 International Federation for Cell Biology
Related Docs
View other Related Docs
1. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
2. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
3. Investigating the Seroconversion Patterns of Specific Antibodies Against Various Antigens of Sars-Cov-2 in Hospitalized Covid-19 Patients and Vaccinated Individuals, Archives of Clinical Infectious Diseases (2024)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Ahmad Nejati (1)
Other Related Docs
4. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
5. Covid-19: From the Molecular Mechanisms to Treatment, Tanaffos (2022)
6. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
7. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
8. Lymphopenia in Covid-19: Therapeutic Opportunities, Cell Biology International (2020)
9. Investigation of Durability of Sars-Cov-2-Specific Igg and Igm Antibodies in Recovered Covid-19 Patients: A Prospective Study, Avicenna Journal of Medical Biotechnology (2022)
10. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
11. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
12. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
13. Spatial Transcriptomics and Single Cell-Rnaseq Reveals Cellular Heterogeneity of Sars-Cov-2 in Lung Tissues and Global Mutational Patterns in Covid-19 Patients, Journal of Medical Virology (2025)
14. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
15. Future Developments in Biosensors for Field-Ready Sars-Cov-2 Virus Diagnostics, Biotechnology and Applied Biochemistry (2021)
16. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
17. Improvement of the Inactivated Sars-Cov-2 Vaccine Potency Through Formulation in Alum/Naloxone Adjuvant; Robust T Cell and Anti-Rbd Igg Responses, Iranian Journal of Basic Medical Sciences (2022)
18. Sars-Cov-2 Intrahost Evolution in Immunocompromised Patients in Comparison With Immunocompetent Populations After Treatment, Journal of Medical Virology (2023)
19. Epitope Mapping of Neutralising Anti-Sars-Cov-2 Monoclonal Antibodies: Implications for Immunotherapy and Vaccine Design, Reviews in Medical Virology (2022)
20. Transient Increased Immunoglobulin Levels in a Hyper-Igm Syndrome Patient With Covid-19 Infection, Allergologia et Immunopathologia (2021)